scholarly journals Tissue-Engineered Carotid Artery Interposition Grafts Demonstrate High Primary Patency and Promote Vascular Tissue Regeneration in the Ovine Model

Polymers ◽  
2021 ◽  
Vol 13 (16) ◽  
pp. 2637
Author(s):  
Larisa V. Antonova ◽  
Evgenia O. Krivkina ◽  
Viktoriia V. Sevostianova ◽  
Andrey V. Mironov ◽  
Maria A. Rezvova ◽  
...  
Keyword(s):  
Growth Factor ◽  
Carotid Artery ◽  
Vascular Tissue ◽  
Layer Structure ◽  
Primary Patency ◽  
Long Term Results ◽  
Preclinical Development ◽  
Vascular Prostheses ◽  
Stromal Cell Derived Factor ◽  
Endothelial Growth Factor

Tissue-engineered vascular graft for the reconstruction of small arteries is still an unmet clinical need, despite the fact that a number of promising prototypes have entered preclinical development. Here we test Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)Poly(ε-caprolactone) 4-mm-diameter vascular grafts equipped with vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and stromal cell-derived factor 1α (SDF-1α) and surface coated with heparin and iloprost (PHBV/PCL[VEGF-bFGF-SDF]Hep/Ilo, n = 8) in a sheep carotid artery interposition model, using biostable vascular prostheses of expanded poly(tetrafluoroethylene) (ePTFE, n = 5) as a control. Primary patency of PHBV/PCL[VEGF-bFGF-SDF]Hep/Ilo grafts was 62.5% (5/8) at 24 h postimplantation and 50% (4/8) at 18 months postimplantation, while all (5/5) ePTFE conduits were occluded within the 24 h after the surgery. At 18 months postimplantation, PHBV/PCL[VEGF-bFGF-SDF]Hep/Ilo grafts were completely resorbed and replaced by the vascular tissue. Regenerated arteries displayed a hierarchical three-layer structure similar to the native blood vessels, being fully endothelialised, highly vascularised and populated by vascular smooth muscle cells and macrophages. The most (4/5, 80%) of the regenerated arteries were free of calcifications but suffered from the aneurysmatic dilation. Therefore, biodegradable PHBV/PCL[VEGF-bFGF-SDF]Hep/Ilo grafts showed better short- and long-term results than bio-stable ePTFE analogues, although these scaffolds must be reinforced for the efficient prevention of aneurysms.

scholarly journals Results of long-term patency of small-diameter biodegradable vascular prostheses with atrombogenic drug coating of sheep model

2021 ◽  
Vol 10 (2) ◽  
pp. 36-39
Author(s):  
E. O. Krivkina ◽  
L. V. Antonova
Keyword(s):  
Growth Factor ◽  
Vascular Tissue ◽  
Small Diameter ◽  
Layer By Layer ◽  
Sheep Model ◽  
Vascular Prostheses ◽  
Polymer Framework ◽  
Endothelial Growth Factor ◽  
Drug Coating

Background. Preclinical tests of biodegradable small diameter vascular prostheses on a sheep model have been carried out.Aim. To assess the results of long-term patency and remodeling of biodegradable vascular prostheses based on polyhydroxybutyrate / valerate and polycaprolactone with an atrombogenic drug coating in a large laboratory animal model.Methods. We researched vascular prostheses made of polyhydroxybutyrate / valerate and polycaprolactone (PHBV/PCL) 4 mm in diameter with layer-by-layer vascular endothelial growth factor incorporated into the polymer framework, the main fibroblast growth factor, chemoattractant molecule containing SDF-1a (GFmix) surface, and additional modifying drug surface heparin and iloprost (PHBV/PCL/ GFmix/Heparin/Iloprost). Animals with implanted synthetic Gore-Tex vascular grafts with a diameter of 4 mm were included into a comparison group.Results. After one day of implantation it was revealed that the patency of biodegradable PHBV/PCL/GFmix/Heparin/Iloprost prostheses was 62.5%, while synthetic Gore-Tex prostheses were thrombosed in 100% of cases. At the same time, after 18 months of implantation, the patency of biodegradable vascular PHBV/PCL/ GFmix/Heparin/Iloprost prostheses decreased to 50%. Passable drug-eluting polymer grafts were completely resorbed after 18 months of implantation, and aneurysmically expanded newly formed vascular tissue was formed in their place.Conclusion. Vascular prostheses made of polyhydroxybutyrate/valerate and polycaprolactone showed better long-term patency results than synthetic prostheses used in the clinical practice. However, the strengthening of the external framework of the prostheses is required in order to prevent the formation of aneurysms. 

Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery

Circulation ◽  
1995 ◽  
Vol 91 (11) ◽  
pp. 2793-2801 ◽  
Author(s):  
Takayuki Asahara ◽  
Christophe Bauters ◽  
Christopher Pastore ◽  
Marianne Kearney ◽  
Susan Rossow ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Carotid Artery ◽  
Intimal Hyperplasia ◽  
Local Delivery ◽  
Vascular Endothelial ◽  
Endothelial Growth Factor

scholarly journals Neurotrophin-3 accelerates reendothelialization through inducing EPC mobilization and homing

2020 ◽  
Vol 15 (1) ◽  
pp. 241-250
Author(s):  
Yan Chen ◽  
Jian Cao ◽  
Weixia Peng ◽  
Wen Chen
Keyword(s):  
Growth Factors ◽  
Carotid Artery ◽  
Animal Experiments ◽  
Flow Chamber ◽  
Control Group ◽  
Angiogenic Growth Factors ◽  
Neurotrophin 3 ◽  
Stromal Cell Derived Factor ◽  
Intravascular Stent ◽  
Endothelial Growth Factor

AbstractRapid endothelialization is an effective way to treat intimal hyperplasia after intravascular stent implantation. Blood vessels and nerves coordinate with each other in function, while neurotrophin-3 (NT-3) is an important class of nerve growth factors. Our study found that NT-3 promoted endothelial progenitor cell (EPC) mobilization, and the proportion of EPCs in peripheral blood was increased by 1.774 times compared with the control group. Besides, NT-3 promoted the expression of stromal cell-derived factor-1α (SDF-1α), matrix metalloproteinase-9 (MMP9), and chemokine (C-X-C motif) receptor 4 (CXCR4) in EPCs, which increased by 59.89%, 74.46%, and 107.7%, respectively, compared with the control group. Transwell experiments showed that NT-3 enhanced the migration of EPCs by 1.31 times. Flow chamber experiments demonstrated that NT-3 captured more circulating EPCs. As shown by ELISA results, NT-3 can promote the paracrine of vascular endothelial growth factor, interleukin-8, MMP-9, and SDF-1 from EPCs. Such increased angiogenic growth factors further accelerated the closure of endothelial cell scratches. Additionally, EPC-conditioned medium in the NT-3 group significantly inhibited the proliferation of vascular smooth muscle cells. Then animal experiments also illustrated that NT-3 prominently accelerated the endothelialization of injured carotid artery. In short, NT-3 accelerated rapid reendothelialization of injured carotid artery through promoting EPC mobilization and homing.

Sign in / Sign up

Export Citation Format

Share Document